• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠癌、乳腺癌、前列腺癌和肺癌患者血清骨唾液蛋白和骨桥蛋白水平升高。

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

作者信息

Fedarko N S, Jain A, Karadag A, Van Eman M R, Fisher L W

机构信息

Division of Geriatrics, Department of Medicine, The Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA.

出版信息

Clin Cancer Res. 2001 Dec;7(12):4060-6.

PMID:11751502
Abstract

PURPOSE

Histological studies have shown that the two sialoproteins, bone sialoprotein (BSP) and osteopontin (OPN), are induced in multiple types of cancer. We have recently found that these proteins are bound in serum to complement factor H and that the complex must be disrupted to generate free protein to measure their total levels. We hypothesized that measuring total BSP and OPN levels would provide informative markers for the detection of cancer.

EXPERIMENTAL DESIGN

As a proof of concept study, serum from patients with diagnosed breast, colon, lung, or prostate cancer (n = 20 for each type) as well as normal serum (n = 77) were analyzed using competitive ELISAs developed for BSP and OPN. Sensitivity, specificity, as well as positive and negative predictive values were determined for each sialoprotein and cancer type. The relationship between sensitivity and specificity was profiled by receiver operating characteristic curves.

RESULTS AND CONCLUSIONS

Determined values for serum BSP in ng/ml were 285 +/- 19 for prostate, 373 +/- 19 for colon, 318 +/- 18 for breast, 155 +/- 11 for lung cancer sera, and 154 +/- 13 for normal sera. Values of OPN in ng/ml were 653 +/- 39 for prostate, 449 +/- 22 for colon, 814 +/- 53 for breast, 724 +/- 33 for lung, and 439 +/- 30 for normal sera. The assays provide a high degree of sensitivity and specificity that enables the detection of colon, breast, prostate, and lung cancer.

摘要

目的

组织学研究表明,两种唾液酸蛋白,即骨唾液酸蛋白(BSP)和骨桥蛋白(OPN),在多种类型的癌症中被诱导产生。我们最近发现,这些蛋白在血清中与补体因子H结合,并且必须破坏该复合物才能产生游离蛋白以测量其总水平。我们假设测量总BSP和OPN水平将为癌症检测提供有用的标志物。

实验设计

作为概念验证研究,使用针对BSP和OPN开发的竞争性酶联免疫吸附测定(ELISA)分析了已确诊的乳腺癌、结肠癌、肺癌或前列腺癌患者的血清(每种类型n = 20)以及正常血清(n = 77)。确定了每种唾液酸蛋白和癌症类型的敏感性、特异性以及阳性和阴性预测值。通过受试者工作特征曲线描绘了敏感性和特异性之间的关系。

结果与结论

前列腺癌血清中BSP的测定值为285±19 ng/ml,结肠癌为373±19 ng/ml,乳腺癌为318±18 ng/ml,肺癌血清为155±11 ng/ml,正常血清为154±13 ng/ml。OPN的测定值在前列腺癌血清中为653±39 ng/ml,结肠癌为449±22 ng/ml,乳腺癌为814±53 ng/ml,肺癌为724±33 ng/ml,正常血清为439±30 ng/ml。这些检测方法具有高度的敏感性和特异性,能够检测出结肠癌、乳腺癌、前列腺癌和肺癌。

相似文献

1
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.结肠癌、乳腺癌、前列腺癌和肺癌患者血清骨唾液蛋白和骨桥蛋白水平升高。
Clin Cancer Res. 2001 Dec;7(12):4060-6.
2
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.原发性乳腺癌患者的血清骨唾液蛋白是后续骨转移的一个预后标志物。
Clin Cancer Res. 1999 Dec;5(12):3914-9.
3
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.非特异性交叉反应抗原50/90在乳腺癌、肺癌和结肠癌患者中升高。
Cancer Res. 1994 Mar 1;54(5):1227-34.
4
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.转移性乳腺癌患者血浆骨桥蛋白水平升高与肿瘤负荷增加及生存率降低相关。
Clin Cancer Res. 1997 Apr;3(4):605-11.
5
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.小整合素结合配体N-连接糖蛋白基因家族在不同癌症中的表达
Clin Cancer Res. 2004 Dec 15;10(24):8501-11. doi: 10.1158/1078-0432.CCR-04-1072.
6
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.骨桥蛋白作为胰腺腺癌生物标志物的评估
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):487-91.
7
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.阿那曲唑治疗的绝经后晚期乳腺癌患者血清骨保护素和骨桥蛋白水平
Endocr Relat Cancer. 2004 Dec;11(4):771-9. doi: 10.1677/erc.1.00775.
8
Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.肝细胞癌患者血浆骨桥蛋白水平升高。
Am J Gastroenterol. 2006 Sep;101(9):2051-9. doi: 10.1111/j.1572-0241.2006.00679.x. Epub 2006 Jul 18.
9
Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.骨基质蛋白在人类乳腺癌中的表达:在微钙化形成及骨转移发生中的潜在作用
Bull Cancer. 1997 Jan;84(1):17-24.
10
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.肿瘤细胞是人类乳腺癌中骨桥蛋白和骨唾液蛋白表达的来源。
Lab Invest. 1999 Jul;79(7):869-77.

引用本文的文献

1
Diagnostic accuracy of serum biomarkers MMP11 and SPP1 in non-small cell lung cancer: an analysis of sensitivity, specificity, and area under the curve.血清生物标志物MMP11和SPP1在非小细胞肺癌中的诊断准确性:敏感性、特异性及曲线下面积分析
Transl Lung Cancer Res. 2025 Apr 30;14(4):1197-1211. doi: 10.21037/tlcr-2024-1068. Epub 2025 Apr 25.
2
Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis.用于改善结直肠癌诊断的血清生物标志物的鉴定与验证
Cancer Med. 2024 Dec;13(23):e70460. doi: 10.1002/cam4.70460.
3
IBSP Promotes Breast Cancer Bone Metastasis and Proliferation via BMP-SMAD Signaling Pathway.
IBSP 通过 BMP-SMAD 信号通路促进乳腺癌骨转移和增殖。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2153. doi: 10.1002/cnr2.2153.
4
The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.细胞外基质和整合素黏附复合体相关分子在前列腺癌生物标志物发现中的潜力
Biomedicines. 2023 Dec 28;12(1):79. doi: 10.3390/biomedicines12010079.
5
The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.PANoptosis相关特征表明了胶质瘤的预后和肿瘤免疫浸润特征。
Front Mol Neurosci. 2023 Jul 12;16:1198713. doi: 10.3389/fnmol.2023.1198713. eCollection 2023.
6
Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.肺腺癌全景中核心基因的评估及多组学水平改变的探索。
Am J Transl Res. 2023 Mar 15;15(3):1550-1568. eCollection 2023.
7
Osteopontin as a Tumor Marker in Ovarian Cancer.骨桥蛋白作为卵巢癌的肿瘤标志物
J Midlife Health. 2022 Jul-Sep;13(3):200-205. doi: 10.4103/jmh.jmh_52_22. Epub 2023 Jan 14.
8
Eight Aging-Related Genes Prognostic Signature for Cervical Cancer.用于宫颈癌的八个衰老相关基因预后特征
Int J Genomics. 2023 Feb 25;2023:4971345. doi: 10.1155/2023/4971345. eCollection 2023.
9
SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer.SPP1 是一种与卵巢癌肿瘤浸润免疫细胞相关的预后相关生物标志物。
BMC Cancer. 2022 Dec 30;22(1):1367. doi: 10.1186/s12885-022-10485-8.
10
Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.癌症相关细胞外囊泡 CBFB 促进乳腺癌进展的侵袭表型、逃避氧化应激以及对骨转移促进因子的优先倾向。
Dis Markers. 2022 Jul 19;2022:8446629. doi: 10.1155/2022/8446629. eCollection 2022.